All Episodes
PharmaTalkRadio — 550 episodes
What’s Next in Immuno-Oncology - A Visionary Conversation with Dr Ira Mellman
New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem
Developing a Global Clinical Trial Strategy for Emerging Biotechs
How Pharma Teams Evaluate Biotech Companies for Partnerships and Acquisitions
What to Expect at Partnerships with Sites 2026
Unlocking Unstructured Data with AI for Optimized Protocol Development
Bridging Access Gaps: Sponsor-Led Enablement of Research-Naïve Sites to Expand Patient Reach
Building Trust-Driven Partnerships: AstraZeneca’s Concierge Approach to Accelerating Site Activation and Enrollment
Eli Lilly on Site Enablement: Co-Designing Solutions with Sites
What a Strategic Partnership Looks Like in Practice: Inside the Takeda–Basil Collaboration That Delivered Tenfold Enrollment
Using Digital Technologies to Enhance Patient Experience and Better Manage Supply Chain
Ensuring Sustainability Throughout Drug and Device Development
Utilizing AI to Facilitate Combination Product Development
Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success
Advances and Opportunities in Dual Chamber Injectables
How Evinova is Integrating AI into Clinical Development to Bring Big Impact to Big Pharma
How Bayer Reorganized Their Clinical Operations Structure for Efficiency and Cost Savings
How Amicus Embedded Patient Advocacy into its Corporate DNA
Designing Clinical Trials Balancing Simplicity with Complexity
Platform Approaches to Streamline Combination Product Development
What is the State of Clinical Trial Patient Matching Right Now?
Balancing Innovation and Practicality in Immuno-Oncology Dose Selection
Leveraging Local HCPs to Decentralize Clinical Research in North Carolina
Using Patient Engagement and Digital Innovation to Elevate Patient Insights and Outcomes
What to Expect at the 2026 Patients as Partners in Clinical Research Conference
The Role of the CMO in BD and M&A Partnering with Pharma
Advances in Payload Delivery and Drug Conjugation
Building Up a CMO Team as Your Company Evolves
Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles
Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform
Insights from Tufts CSDD into Evolving Trial Partnerships Models
ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma
Understanding the Immunological Effects of Radiopharmaceuticals
How J&J Is Integrating Patient Centricity Across the Enterprise
Biogen's Nicole Murphy on Drug Delivery Innovation and the Acquisition of Alcyone Therapeutics
What to Expect at the 2026 IO360° Summit
CMOs Working Flexibly with Consultants and Fractional Expertise
Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs
How Patient Organizations are Bridging Patient Inclusivity Gaps at the Site-Level
How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost
How to Embed Clinical Research in Rural and Frontier Health Systems
Optimizing the Value Proposition in Small Companies with Limited Budgets
From the DPHARM 2024 Archives: Biogen Pilot on Using Vocal Biomarkers to Identify Potential Participants for Clinical Trials
Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement
Ensuring Continuity in Patient Insights to Strengthen Medicine Development
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach
Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy
De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing
Balancing Between Concentration and Volume when Developing Patient-Centric Biologics
Directors' Talk DPHARM 2025 - AI Sessions; Part III
Innovations in Manufacturing to Make CAR-T More Accessible and Affordable
Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches
Catalyzing Change: The Business Imperative of Patient-Centric Drug Development
How Emerging Biopharma CMOs Can Better Partner with Patient Organizations
Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges
What to Expect at the CRAACO: Clinical Research as a Care Option 2025 Event
Directors' Talk PODD 2025 - Keynotes & Key Themes
Enhanced Strategic FDA Collaboration: Working with CDER and CBER
Biomaterial Implants to Reduce Patient Burden and Improve Adherence
Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge?
2025 Biotech Markets & Immuno-Oncology Outlook
Directors' Talk DPHARM 2025 - Pharma from the Trenches; Part II
Directors' Talk DPHARM 2025 - Keynotes & Key Topics; Part I
Streamlining Effective Patient Engagement through Pharma-Patient Advocacy Collaboration
Lessons Learned in the Development and Introduction of Closed Loop Systems
Best Practices and Potential Pitfalls Enriching Clinical Trials with PROs
Operationalizing the Patient Voice for Long-Term Protocol Planning and Execution
Navigating Data Quality and Scalability Challenges when Using Real-World Data from EHRs
Addressing the Realities of Scaling T-Cell Therapies for Patient Access and Affordability
The Current Status of Patient Centricity in Medicine Development
Patients as Partners Caregiver Keynote - The Life-Changing Power of a Clinical Trial
Bispecific Antibodies for PD-1 and VEGF: Impact and Market Dynamics for IO Landscape
Sustained Release Innovations to Reduce Patient Burden
How Pharma Is Adopting Generative AI Across Clinical Development
Tufts Center for Study of Drug Development on Evolving Clinical Trial Partnerships
New Approaches to Achieve Targeted Brain Delivery Without Increasing Toxicity
Partnering with Patients in Clinical Development Using the Biopsychosocial Model
Vaccine Delivery Innovations
How PALADIN Consortium Aims to Enhance Efficient Patient Advocacy-Industry Collaborations
What CMOs Need to Know and Do When Preparing for Product Launch
What to Expect at the 2025 Patients as Partners EU Conference
Understanding Financial Barriers to Getting More Coverage for Patients in Clinical Trials
How Montefiore Gets Early Stage Clinical Trials to Under-Resourced Communities
Investment Trends in Immuno-Oncology
Advances in Pulmonary Delivery of Biologics
Strategies for CMOs to Scale Up Effectively as Their Biotech Company Evolves
Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness
Payer Perspectives on Drug Delivery
Patient Engagement: Practical Approaches for Emerging Biotech CMOs
Immuno-Oncology Debate 2024 on Solving Cancer’s Top Challenges
CMO Misunderstandings about Clinical Operations and How to Improve
How Roche is Maximizing the Impact of Patient Insights in Early Development
Designing and Developing Drug Delivery for Lower and Middle-Income Countries
Making Clinical Research a Feasible Care Option Using Modern Software Infrastructure
Using Patient Insights Meaningfully throughout the Medicine & Disease Lifecycle
Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials
Incorporating Quantitative Values of Patient Perspectives into Trial Design
Accessing a Novel Source of Patient Experience Data to Improve Clinical Research
Empathy and Behavioral Science in ePROs to Increase Data Collection Adherence
Antiviral Drug Development: Overcoming Challenges to the Current Model
Unlocking Pre-Enrollment Data to Help Sponsors Recruit and Enroll More Patients
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
The History of Tumor Vaccines, and Why the Newest RNA Cancer Vaccines Might Work
What Biotech CEOs Need to Know about Developing a Commercialization Roadmap
Simplicity in Technology Delivery for Clinical Trials
Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral
Combining AI and Empirical Science to Advance Cancer Immunotherapies
The Personal Impact of a Clinical Trial
The Future of Patient-Centricity: Advancing Frameworks to Achieve Greater Impact
Using AI to Accelerate the Next Generation of Oncology Immunotherapies
Immuno-Oncology Cell Therapy Data Analytics: What and How to Measure
What to Expect at CRAACO: Clinical Research as a Care Option 2024, in 5 Minutes
How to Enhance Clinical Trial Participation in Diverse Linguistic Backgrounds
Patient Engagement Advocate on Collaborating Successfully with Pharma
What to Expect at DPHARM 2024, with DPHARM Directors
Astellas Head of Patient Centricity on Patient-Centric Medicine Development
Preferences in Decentralization and Digitalization of Pediatric Clinical Trials
What CMOs Need to Know about Partnering with Hospitals & Clinical Research Sites
How CMOs Build a Network of Consultants
CMO Insights and Advice on Tailoring Your Pitch to Investors
Transitioning from Early Stage to Registrational/Pivotal Stage Development
Using Sustainability to Empower Patient Engagement Goals in Medicine Development
Discoveries from the Clinic that Help Inform IO Cell Therapy Moving Forward
Maximizing Regulatory Interactions
The CMO as a Translational Scientist
Optimizing the Integration of Mobile and Patient-Facing Tech in Clinical Trials
Delivering Exceptional Clinical Trial Experiences for Patients
ctDNA Potential for Prognostic Stratification, Tumor Insights & Drug Development
What to Expect at the 2024 Patients as Partners EU Conference
Taking Lessons from Manufacturing Immunotherapies to Accelerate Development
Enhancing Solubility with Novel Excipient Technologies
Measuring the Value of DCTs and Hybrid Models
Navigating and Adopting Innovation in a Post- Pandemic World
Turning a Search for Lung Cancer Biomarkers into a Patient Empowerment Community
Engaging All Stakeholders for Clinical Trial Patient Engagement and Value
Optimizing Medicine Development for Real-World Efficacy in Patients
How CMOs can Support the Overarching Process of a Fundraising
Prioritizing Development Programs that Align with Fundraising Catalysts
Interacting with Different Types of Investors as a CMO
Developing Internal and External Communication Strategies
What CMOs Need to Know About Medical Affairs
Achieving Targeted Delivery of Gene Editing Therapies
The Promise and Challenges of Ultrasound-Mediated Delivery
The Future of Digital Technology in the Connected Device Space
New Approaches in CNS/PNS Delivery
Precision Ophthalmic Delivery
Delivery Challenges from the Oncology Pipeline
Novel Nasal Products and Formulations
Overcoming Barriers to Adoption of Transdermal Delivery
Addressing the Clinical Operations Workforce Gap
Evolving US Clinical Trial Infrastructure for Better Trials & Emergency Response
Community Organization Perspectives on Improving Clinical Trial Initiatives
Patients on How R&D Organizations Can Better Operationalize Trials for Patients
Novartis’ Approach to Making Patients Feel Valued in Clinical Research
How Henry Ford Health Integrated Clinical Trials into Clinical Care
Reimbursement Challenges with Clinical Trials
Democratizing Access: Enabling All Care Locations to be Research Locations
Strategies for Building a Successful Clinical Research Team in the Care Setting
How to Optimize Inventory and Sample Management for Clinical Trial Health
Ensuring That Sites Are Set Up for Trial Success, Using Data and Technology
Innovating Patient Recruitment: A Conversation with BBK Worldwide Founders
10th Annual Mobile Tech in Clinical Trials: What to Expect in under 10 Minutes
CRAACO Director's Note Podcast on What to Expect in Under 6 Minutes
Current Challenges in Vaccine Delivery and Distribution
Providing the Right Level of Value to the Patient that Creates Value
Enhancing the Interferon Pathway to Attack Cancer
Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies
Investment Trends in IO
Investment and Collaboration Strategies in Cell and Gene Therapy
Mechanisms of Immune Evasion Mediated by Hypoxia- Inducible Factors
Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri
Regeneron’s Approach to Strategic Collaborations, Licensing and Business Dev.
Panel: Targeted Radiotherapy and the Impact on IO
What’s Next on the IO Radar? Top 10 Recommendations from Dr Andrew Baum, Citi
KEYNOTE FIRESIDE CHAT with Dr Robert Langer and Dr Ester Caffarel-Salvador
Panel: Role of China in the BD Process
Gaining “Hard-to-Reach” Patients’ Input During the Global COVID Pandemic
How Janssen is Collaboratively Working with Patients and Sites to Advance DCTs
How Merck is Partnering with Communities to Support Clinical Research
Sanofi’s New Initiatives Firmly Embedding Patient Experience & Perspectives
Reflections on Alnylam and Conquering Delivery
Patient Involvement Legal Barriers to Be Aware of and Pathways to Overcome Them
Next Generation Immune Checkpoints: Deciphering Key Roles in the TME
Merck Reporting on Site Monitoring, Performance and Database Lock
The Role of RWD in the Development of Remdesivir
De-risking Combination Product Development Involving L Volume Sub Formulations
How Regeneron Got an FDA Approved Therapy for COVID in Record Time
Remote Monitoring to Improve Transitioning Home and Reducing Risk of Readmission
The Pfizer Pledge: Getting to 60% Remote Clinical Trials in 2022
Benchmarking Clinical Operations for Digital Maturity
Innovative Trial Designs to Reduce Patient, Site and Investigator Burden
Addressing the Lack of Structured, Clean Patient Data
Fireside Leadership Lessons: Driving Innovation to Support Patients and Sites
Why Rare Disease Therapeutics Need Early Market Access Planning
Effective Concentration for a Longer Period with Long Acting Injectables
Moderna on Innovating Clinical Trial Partnerships to Expand Access
Regeneron and Novartis on Innovating to Accommodate Growing Pipelines
Development of the Lipid Nanoparticles
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies
Chair’s Opening Presentation with Barbara Lueckel Summary
A Decade After Checkpoints- What Do We Know, What Do We Need to Know and Getting
Achieving Diversity and Inclusion in Oncology Clinical Trials
How Long-Acting Implantables Are Taking Extended Drug Release to the Next Level
Advancements in CART for the Treatment of Glioblastoma
From Carer to Trailblazer: One Man’s Fight to Impact Clinical Research
Cell & Gene Therapy: Current Landscape, Lessons Learned and Paths Forward
What to Expect at the IO360° Summit in 6 Minutes
Solving for the Digital Divide: Building Trust with Mobile Tech for Patients
How Moderna Built a Digital Organization to Transform How Clinical Research Gets
Roche’s Industry Overview on the Drug Delivery Landscape 2022
Leveraging Mobile Technologies in the Development of Novel Digital Endpoints
How Mobile Tech is Enabling Smarter Trial Designs for Better Data and Access
FDA Update on Digital Health Technologies in Clinical Trials Draft Guidance
Taking Patient Involvement in Clinical Publications to New Heights
Partnering with Your Compliance Teams to Advance Meaningful Collaboration
What Statisticians Wish They Could Tell Their Chief Medical Officers
Tackling the Manufacturing Complexity of Complex to Deliver Pipelines
Misaligned Incentives: Physician Perspectives on the Integration of CRAACO
Rewriting the Way We Work Together to Integrate Clinical Care and Research
Volunteering for a Vaccine Trial, Tackling Racial Disparities in Healthcare
How Amgen is RISING Above with Clinical Trial Diversity
A Vision for the Integration of Clinical Research and Care
Addressing Barriers to Patient Community Access through Non-Profit Partnerships
Educating Patients and Non-Research Physicians on Navigating Clinical Research
Long Acting Injectables for Biologics
Where and How DCTs Can Truly Enable and Close the Gaps between Research and Care
Partnering with Health Systems to Enhance Diverse Patient Access in Trials
Novartis’ Approach to Patient Engagement
Workforce Planning & Reducing Churn to Support and Promote CRAACO
Guest Keynote Connecting Communities with the CEO of Etsy
Making Institutional Change to Offer Clinical Research Options in Health Systems
Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous
CMO-CEO Fireside Discussion on Working Through Challenges
Building Trust to Ensure Diversity, Equity, Inclusion in Clinical Research
Drug Delivery Pipeline and Technologies, a Year in Review
How Eli Lilly is Diversifying and Engaging Patients Using DCT Capabilities
Advice for Partnering Between Innovator Drug Delivery Companies and Big Pharma
Fighting to be a True Stakeholder in Clinical Care and the Impact on Diversity
The First 90 Days as a CMO
R&D Veteran on Leading a Biotech through Founding, IPO and Acquisition
Building up a Company Through to Commercialization and Beyond
Best Practices for Cross Functional Communication Strategies for the CMO
Nicholas Warne Drug Delivery Industry
Managing the Partnership Between Big and Small Pharma
Infusing Patient Perspectives Across All of Pfizer
The Changing Environment Around Accelerated Approvals and Regulatory Pathways
Positioning Yourself For Board Roles and What to Expect as a CMO in Biotech
Biotech Financing Options and Their Implications
Building a Work Culture that Attracts and Retains Talent in Biotech
Exploring Ways to Reduce Costs of Developing & Manufacturing Drug Delivery Tech
Taking on the CMO Role at Moderna and Looking to the Future of Biotech R&D
What CMOs Must Know About How Patient Engagement Supports the Entire Biotech
Operationalizing the Integration of Patient Insights
How Sites Using Their Own Technology for Research Benefits All Stakeholders
Adjusting Your eCOA Strategy For Patient Centricity: Expert Advice
Sandoz's Chief Operating Officer Discusses the New Initiative Act4Biosimilars
A Natural Language Collaboration That Helps Cancer Patients Navigate Treatment
12th Annual DPHARM in Under 10 Minutes
Director's Notes on What to Expect at CRAACO: Clinical Research as a Care Option
What to Expect at Mobile Tech in Clinical Trials 2022
5 Minute Overview Podcast on What to Expect at PODD: Drug Delivery
Key Role of Strategy and Media in Improving Clinical Trial Enrollment Diversity
How CMOs Can Evaluate Potential Outsourcing Partners Effectively
Is the End of SDTM in Sight?
What Adapting During COVID-19 Taught Us About Innovating Drug Development
A Vision for the Future of Drug Delivery: Patients Interacting Less with Disease
How Listening Tech Disrupts Clinical Research to Create Patient-Centric Trials
On-the-Ground Perspective on Putting Decentralized Strategies in Clinical Trials
Biotech CEO Keynote, Dr Ron Cohen, from Chief Medical Officer Summit 360° 2021
R&D Veteran Keynote, Dr Jo Viney, from Chief Medical Officer Summit 360° 2021
10th Annual Chief Medical Officer Summit 360º in a Nutshell
The Case for Sites Using Their Own Tech to Accelerate Research and Reduce Burden
5 Talks to Watch (and Why) at IO360º 2022 with Strategic Advisor Dr Dan Chen
8th Annual Immuno-Oncology 360° Summit: What to Expect in 7 Minutes
Patients as Partners EU 2022 in 5 Minutes
How Artificial Intelligence Is Creating Better Clinical Trials, with Saama
Making the Leap from IV to Subcutaneous, with Halozyme's ENHANZE® Technology
J&J Vision on Progress in Eyecare and Meeting the Needs of Future Patients
Flexible Data Collection and Best DCT Strategies: Advice from an Expert
Building a Successful Relationship with your Development Partner
9th Annual Chief Medical Officer Summit 360° Overview in 5 Minutes
10 Year Review on Drug Delivery
8th annual Mobile in Clinical Trials in 5 Minutes
PODD 2021 in 7 Minutes with Director, Valerie Bowling
Ferring on Creating a First-in-Class Microbiome-Based Therapeutic
DPHARM in 10 Minutes with Director Valerie Bowling
The Biotech Incubator Helping Entrepreneurs Launch Companies to Advance Health
How and When to Pursue Decentralized Clinical Trials: Conversation with Experts
How to Utilize Technology to Truly Increase Diversity in Clinical Trials
Insights from CRAACO 2020 and Looking to the Future
The Practical Implementation of Sensors in the Changing Drug Development World
Patients as Partners Europe 2021 Overview in 5 Minutes
Innovations & Novel Approaches in IO Imaging & Assessing Responses
HLA Loss and the Impact on Immunotherapy
Cell & Gene Therapy Debate: Intrinsic Editing vs Systemic Combination
Operational Dynamics of Implementing & Managing Basket Trials
Overcoming Site Regulatory Issues to Optimize Clinical Quality
Evolution of Regulatory Policy For Cell/Gene Therapy
Centralized vs Decentralized Manufacturing
Next Generation Bispecifics in Solid Tumors
Ariella Chivil's Immunotherapy Trial Pathway
Insitu Vaccinations vs Systemic Neo-Epitope Vaccinations
What Do Next Generation of Immunotherapies Need to Look Like to Move the Needle?
Using Sensor Technology to Deploy Decentralized Trials and Improve Patient Care
Current Issues and Potential Solutions for Site Audit Readiness and Monitoring
5 Minute Overview of 8th Annual CMO Summit 360º
The Future of Clinical Research and the Innovation from the COVID-19 Pandemic
Connecting Care and Research for the Patient with a Decentralized Trial Model
Remote Monitoring for Clinical Research in the Digital Age
Solving for the Patient Retention Problem in Clinical Research
IO Combinations 360° Overview in 7 Minutes
Enabling Clinical Trial Continuity with Live Video Visits
Roche's Dr Barbara Lueckel's Opening Remarks and the 2018 Year in Review
How a Gene Therapy for Duchenne Muscular Dystrophy Came to Be
How a Covid-19 Research Study was Formed with Oracle, Javara and Wake Forest
IO Biomarker Discovery & Personalized Cancer Therapy Development with Personalis
The Impact of COVID-19 on Clinical Trials: Where are We? And Where are We Going?
7th Annual Mobile in Clinical Trials Overview in Under 5 Minutes
KPIs that Support Innovation for Patient-Engagement
Starbucks: Innovation for the End User Experience
Transparency and the Future of Patient Expectations
Turning Genes into Medicines: Gene Therapy for Genetic Disease
Formulation & Device Lifecycle Management for Biotherapeutics
Future Outlook for Novel Drug Delivery
Modality Fluid Development: Evolving Pipelines and Drug Delivery Solutions
MedTech Fireside Chat: The Journey of an Emerging Medical Device Company
Case Study: Forming and Managing a Drug Delivery Alliance
Supporting Business Models for Scaled Connected Health Drug Delivery Products
Utilizing Digital Health Data to Improve Management, Prevention & Wellness
Understanding Jansen's Metaphyseal Chondrodysplasia
The Collective Struggle to Evolve Data and Analytics Culture & Capabilities
Re-Thinking Clinical Development - Using Historical Data to Transform Trials
The Evolution of Using Real World Data to Create Trial Readiness Cohorts
The PD-FIDI: Developing a Digital Endpoint for Parkinson's Disease
Planning For and Addressing Missing Data in Mobile Clinical Trials
Balancing Innovation with Solid Common Sense to Deliver Innovative Medicines
Virtual Trials: What are We Striving for and Measurements of Success
Escaping Pilotville: How to Scale Mobile / Digital Deployment in Clinical Trials
Merck's Strategy to Mobilize Mobile Efforts and Engineer for Scale
What Does a Successful Digital Trial Look Like?
Advocating for People Managing Hermansky-Pudlak Syndrome
Maintaining Clinical Trial Patient Engagement in COVID with Be the Partner
Setting Up Therapeutic + Vaccine Programs for COVID-19: Lessons Learned
Understanding Spinal Muscular Atrophy: A Chief Scientific Officer's Perspective
Changing How We Treat Systemic Sclerosis
New Opportunities for Cell Therapy Combinations
PD1 Resistance with a Multi-Omic Approach
Updates on PARP Inhibition
Leveraging the Tumor Microenvironment for IO Therapy
Updates on Bintrafusp alfa/M7824 Clinical Data
NKTR-214: Harnessing the IL-2 Pathway in Combination Immunotherapies
Advancing Bispecifics for Combination Immunotherapy
How AI, Machine Learning and Big Data are Used to Inform Combinations
Weighing Your Options in Considering Clinical Trials from a Patient Perspective
Understanding the Goals of Care vs Research
6 Min Podcast on What to Expect at the 7th Annual Patients as Partners
How to Integrate Industry Sponsored Clinical Trials Into Your Health System
How Sanford Health Systems Increased Clinical Trial Participation to 10%
Keynote: Surgeon’s Perspective on Integrating Clinical Care & Clinical Research
How Wilmington Health is Streamlining Integration of Clinical Research & Care
Addressing Barriers Health Systems Face in Integrating Clinical Care & Research
Effectively Democratizing Access to Clinical Trials for All
Delivering an Innovative, Patient-Centric Delivery System
Ophthalmology: Exploring Other Routes of Administration
Transforming Cardiovascular Treatment with Pulmonary Delivery
MRI-Guided Focused Ultrasound and the Delivery of Therapeutics to the Brain
Better Strategies to Inform Patients on Clinical Research & Trial Participation
Chief Patient Advocate/Officer: Driving Culture Change from the Top Down
How Novartis Includes Patient Input into All Aspects of a Clinical Study
Patients as Partners in Clinical Research EU 5 Min Upcoming Conf Summary
Partnering with Patients on Clinical Development Protocols
Improving Clinical Research and Trials Through Pharma/Advocacy Partnerships
Engaging with Communities to Educate and Enroll Diverse Populations
Mapping Out the Patient Decision Journey
FDA Patient Engagement Synergistic Efforts
The Democratization of Patient Data Ownership: Returning Results
Cell & Gene Therapy Day Overview in 4 minutes
2020 Immuno-Oncology 360° Summit Overview in 10 Minutes
Fireside Chat with an R&D Veteran
Designing Clinical Trials for Gene Therapy - A Paradigm Shift
Case Study: Life of a Chief Medical Officer Pre and Post IPO
How the CMO of Sage Therapeutics Positioned a New Indication for FDA Approval
Addressing the Talent Gap in Biotech - Recruit and Retain
How to Navigate the Development Path from CMO to CEO
How do Patients Become Partners in the Sharing of Data to Advance Science?
Best Practices for Pharma - Patient Advocacy Partnerships
Merck's Next Phase of Patient Centricity in R&D
Clinical update on AMG 420, an anti-BCMA BiTE®
Connecting Employee-Centric Culture to Patient-Centric Culture
Eliciting Patient Experience Data to Understand Medicines Benefits/Disadvantages
Understanding the Language of Patients - The Value of Health Literacy
UCB and Parkinson's UK Collaboration Improve a Trial through Patient Involvement
Improving T Cell Therapies via Next Generation Technologies
Monetizing Science: Turning an Asset into Value through IPOs
IDO Changes the T-cell Balance in the Tumor Microenvironment
Insights from Deal Trends: Betting on Tumor Immunology
Living with Alzheimer’s from a Young Patient's Perspective
Organizational and Digital Restructuring to Scale Mobile Clinical Trials
How to Align the Promise of Technology with the Patient Voice
The Role of Digital Biomarkers and the Impact on Drug Delivery
PODD: Partnership Opportunities in Drug Delivery 2019 Overview in 4 Minutes
A Patient Perspective on Living with Parkinson's Disease and the GDNF Trial
The Future of Mobile Data in Clinical Trials: Challenges and Opportunities
Eli Lilly: How to Launch Multiple Mobile Devices in a Hybrid Setting
Pfizer’s Atopic Dermatitis Clinical Trial with Digital Wearable Technology
Merck’s Digital Health and Al Strategy: Progress Report
How Digital Biomarker Innovation is Modernizing Clinical Endpoints
Regenerative Medicine as a Disrupter in Clinical Trials
6th Annual Mobile in Clinical Trials: What to Expect in 4 Minutes
Estonia, The Digital Republic: Where Patients Own Their Data
Co-Creating the Industry's Scalable Solution for EHR
Bringing Blockchain to Life: Digitizing Clinical Supply Chain in Trials
Bayer: Virtual Assistants for Sites and Patients in Clinical Trials
DPharm: Disruptive Innovations in Clinical Trials 2019 Overview in 5 Minutes
Entrepreneur Data Scientist, Ben Liu on Solving Bottlenecks in Clinical Research
Stories from Bioinspiration to Innovation
Including Wellness in the Pharma Model - How Drug Delivery will be a Key Enabler
Service & Patients in Clinical Trials
Panel: Delivering mRNA Drugs and Vaccines – Progress and Future Outlook
How to Innovate like Amazon to Modernize Clinical Trials
Alzheimer’s Studies: Exploring Registries to Improve Enrollment & Trial Design
4th Annual IO Combinations 360°: What to Expect in 8 Minutes
CAR-T Therapy: Optimization Through Engineering T-cells or Combinations
Combining IO Modalities In a Cost Effective, Patient Beneficial Manner
IO Partnering Strategies In an Increasingly Complex Environment
Next Generation Biomarker and Companion Diagnostics for Predicting Response
Innovations in Immuno-Oncology Imaging
2nd Annual Drug Delivery West - 5 Minute Overview
Modernizing Clinical Trials with IQVIA's Dr Cynthia Verst
Integrating Care and Research with Dr Laura Esserman
Drug Delivery Global Health Challenge
Patient Perspectives on Drug Delivery Needs Present and Future
What are the Regulatory and Ethical Concerns of Integrating Care and Research?
How Can We Work with Medical Practices to Offer Patients Clinical Trials?
Why Are Clinical Trials Not Typically a Care Option?
How to Move Clinical Research into Communities That Would Truly Benefit
Lessons Learned from a Veteran Biotech and Investor MD
Case Study: Preparing for the Challenges of Late Stage Trials
Should Patients Have the Right to Try?
Best Practices in Communication and PR Strategy
Translating Patient Insight and Patient Experience Internally into Deliverables
Progress and Future Outlook of Cancer Immunotherapy
Panel: Engaging Patients By Giving Them their Data
Mobile Technology in Clinical Trials: Clinical Trials Transformation Initiative
How GSK Implemented Pivotal End-to-End Engagement Initiatives at Different Stage
How to Make Patient Involvement Sustainable Throughout Medicines Development
What Does a Truly Patient-Centered Healthcare System Look Like in 5-10 Years?
6th Annual Patients as Partners US: What to Expect in 8 Minutes
How Partnering with Medical Research Charities is Key to Medicines Development
Patients as Partners Europe 3rd Annual What to Expect in 5 Minutes
How Tesaro is Integrating the Patient in the Clinical Development Process
Keytruda in Combo with Chemo in NSCLC
Future Value Generation in Immuno-Oncology
Reflections of the Cancer Moonshot and Future of the Biden Cancer Initiative
Balancing Benefit and Toxicity from Immunotherapeutics
The BioCentury Report on Immuno-Oncology Industry Trends
5th Annual Immuno-Oncology 360˚: 12 minutes of What to Expect
Partnership Opportunities in Drug Delivery 2018: What to Expect 5 Min Podcast
Podcast: From a Zimbabwean Village Kid to a PhD Regenerative Medicine Student
All of Us Research Program, a Nation-wide Initiative from the NIH
Reimagining Clinical Trials with Entrepreneur, Dr Ben Liu, CEO, Trialspark
Blockchain Opportunities for Patient Data Donation and Clinical Research
DPharm Podcast: What to Expect at the 2018 Event in 8 Minutes
Mobile in Clinical Trials Podcast: 3 1/2 Minutes on What to Expect
What to Expect at Rational Combinations 360° 2018 - 5 Min Overview
How to Innovate in the Drug Delivery Space
Key Trends in Drug Delivery: Expert Perspective
How FARA and Horizon Pharma Partnered to Improve Clinical Development
How Takeda Used One or More of the Various Patient Engagement Frameworks
How Patient Research Advocates are Driving R&D: A Patient Case Study
Fireside Chat: Lessons Learned from a Drug Delivery Pioneer and Risk-Taker
Nanotechnology Keynote
Utilizing a Device Platform Technology across Multiple Therapeutic Categories
CEO Keynote Fireside Chat
Addressing R&D Challenges using Drug Delivery Technologies
Panel: Hitting the "Reset" Button on Direct-to-CNS Delivery
Current and Emerging Drug Delivery Needs in Oncology
Building Blocks of IO Clinical Trials - Part 2
Building Blocks of IO Clinical Trials - Part 1
Endpoints News Industry Report on IO Collaborations and Trends
CTTI Report - Mobile Clinical Trials Program: Recommendations on Novel Endpoints
How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes
Lessons Learned from the Journey of a CMO Leader, Michael Rosenblatt, MD
Developing a Pathway for Compassionate Use Cases
2018 Chief Medical Officer Summit Podcast Overview in a Nutshell
Clinical Research as a Care Option, 2nd annual - 3 min Podcast Overview
What to Expect at Clinical Trial Collaborations 2018 – 5 min Podcast
Mobile in Clinical Trials Europe New for 2018 - 4 min Podcast Overview
Patients, a Seat at the Table in Clinical Trials with Pfizer’s Dr Roz Schneider
Reducing the Burden of Type 1 Diabetes with Patient Dana Lewis:DPharm Podcast #5
5th Annual Patients as Partners What to Expect Overview Podcast in 7 Minutes
Wireless Remote Monitoring – DPharm Podcast Series #2
Immuno-Oncology Clinical Trial Operations 4 Min Summary of What to Expect
Patients as Partners EU Overview in 3 Minutes
Roche's Dr Barbara Lueckel Reviews the 2016 Drug Delivery Industry
From the Olympics to Clinical Research
What to Expect at Immuno-Oncology 360° 2018
Why Pharma R&D has to Start Thinking Like a Service Industry and How?
The Gap Between Clinical Care, Patient Involvement & What Patients Want
Digital Solutions Impacting the Economic Efficacy of Clinical Trials
Partnering with Patient Organizations for Advancing Cures
Challenges and Opportunities in Pursuing a New Therapeutic Modality
Partnering with Patients in the Development and Lifecycle of Medicines
Trends and Collaborations in the IO Space
Unlocking the Power of Patient Engagement within Clinical and Commercial
Patients Influencing Policy in the EU
Immuno-Oncology 360°: Business Models for Complex Science by Dr Axel Hoos of GSK
Increasingly Critical Role of Predictive Biomarkers in Cancer Immunotherapy
Important Business Aspects of Immuno-Oncology: Issues and Controversies
Innovative Ways of Patient Involvement in Medicines Development
Addressing Clinical Challenges in Immuno-Oncology
Sequencing of Combination Agents in Immuno-Oncology with Dr Charles Drake
Next Generation of Combination Immunotherapy with Dr Patrick Hwu of MD Anderson
Patients as Partners Europe 7 Minute Overview on What to Expect?
5 Minute Overview of DPharm (Disrupting Clinical Trials) Europe: What to Expect?
Immuno-Oncology 360 Conference in 5 Minutes: What to Expect?
DPharm Team Discuss 2016 Highlights
Pfizer's Blue Sky Approach to Help Transform Clinical Research
Communicating the Good, Bad & Ugly for CMOs and R&D Leaders in Biotech
Clinical Trial Opportunities in Puerto Rico
Alternative Model to Transform a Funding Gap in Rare Disease Clinical Research
A New Economic Solution to Drive Cures to Patients
Partnering with Patients in the Development & Lifecycle of Medicines
Immuno-Oncology Drug Development: Challenges & Next Steps
Making Clinical Trials a Care Option for Patients: Piloting an Infrastructure
Safety Elements of Cancer Immunotherapies: Immune Related Adverse Events
How the Availability of Capital Impacts the Role of the CMO
How Investors Assess R&D Biotech Management
The Journey of a Physician CEO with David Schenkein, MD, CEO, Agios
Clinical Air Episode #14 Consumer Electronics in Clinical Research
Immuno-Oncology: Exploring the Challenges & Potential
Design Thinking for Clinical Trials
Clinical Air Episode #13 Transcelerate & Industry Engagement
Risk Based Monitoring: New Thinking on Clinical Oversight
Clinical Air Episode # 12: Digital Startups & Applications for Clinical Research
Clinical Air Episode #11: How can Digital Complement and Disrupt Clinical Trials
Clinical Air Episode # 10 Patients as Partners in Clinical Trials
Clinical Air Episode # 9 Investing in the Future of Clinical Research
Clinical Air Episode # 8: Investigators as Partners in Clinical Research
Clinical Air Episode # 7: Engaging Patients by Sharing Electronic Clinical Data
Clinical Air #6 Clinical Trial Visits of the Future
Barriers and Limitations in Engaging Patients in Clinical Trials
Clinical Air Episode #5 Applications for Mobile/Sensors in Clinical Research
Clinical Air Episode #4 Clinical Innovation Continuum
Clinical Air Episode #3 Dpharm & Beyond
Clinical Air Episode #2:To Serve Patients in Clinical Trials
Managing the Role of Chief Medical Officer in a Biotech
Navigating the Complexities of Global Clinical Trials
Clinical Air Episode #1: Clinical Trial Calling